The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCAT 2023 | Gene therapy approaches to treating SCD and thalassemia
In this video, Miguel Abboud, MD, American University of Beirut Medical Center, Beirut, Lebanon, briefly comments on some gene therapy approaches which are being considered for the treatment of sickle cell disease (SCD) and thalassemia, due to their ability to ameliorate symptoms of the disease in patients. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
